These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34896517)

  • 61. Staphylococcus aureus Bacteremia in Children: Changes During Eighteen Years.
    Cobos-Carrascosa E; Soler-Palacín P; Nieves Larrosa M; Bartolomé R; Martín-Nalda A; Antoinette Frick M; Bernet A; Pumarola T; Figueras-Nadal C
    Pediatr Infect Dis J; 2015 Dec; 34(12):1329-34. PubMed ID: 26780021
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study.
    Kaasch AJ; Rieg S; Kuetscher J; Brodt HR; Widmann T; Herrmann M; Meyer C; Welte T; Kern P; Haars U; Reuter S; Hübner I; Strauss R; Sinha B; Brunkhorst FM; Hellmich M; Fätkenheuer G; Kern WV; Seifert H;
    Infection; 2013 Oct; 41(5):979-85. PubMed ID: 23539143
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyperglycemia and mortality in elderly patients with Staphylococcus aureus bacteremia.
    Bader MS
    South Med J; 2007 Mar; 100(3):252-6. PubMed ID: 17396726
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Staphylococcus aureus bacteremia after thermal injury: the clinical impact of methicillin resistance.
    Theodorou P; Lefering R; Perbix W; Spanholtz TA; Maegele M; Spilker G; Thamm OC
    Burns; 2013 May; 39(3):404-12. PubMed ID: 23313016
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Distance Between Home and the Admitting Hospital and Its Effect on Survival of Low Socioeconomic Status Population With
    Minejima E; Wang J; Boettcher S; Liu L; Lou M; She RC; Wenzel SL; Spellberg B; Wong-Beringer A
    Public Health Rep; 2022; 137(1):110-119. PubMed ID: 33715536
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
    Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
    Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis.
    Hetem DJ; de Ruiter SC; Buiting AGM; Kluytmans JAJW; Thijsen SF; Vlaminckx BJM; Wintermans RGF; Bonten MJM; Ekkelenkamp MB
    Medicine (Baltimore); 2011 Jul; 90(4):284-288. PubMed ID: 21694650
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.
    Kok J; O'Sullivan MV; Gilbert GL
    J Hosp Infect; 2011 Oct; 79(2):108-14. PubMed ID: 21741724
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
    Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
    Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.
    Ganga R; Riederer K; Sharma M; Fakih MG; Johnson LB; Shemes S; Khatib R
    J Clin Microbiol; 2009 Mar; 47(3):590-5. PubMed ID: 19144813
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study.
    Martirosov DM; Bidell MR; Pai MP; Scheetz MH; Rosenkranz SL; Faragon C; Malik M; Mendes RE; Jones RN; McNutt LA; Lodise TP
    BMC Infect Dis; 2017 Aug; 17(1):534. PubMed ID: 28764660
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
    Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Staphylococcus aureus bloodstream infections in older adults: clinical outcomes and risk factors for in-hospital mortality.
    Big C; Malani PN
    J Am Geriatr Soc; 2010 Feb; 58(2):300-5. PubMed ID: 20070420
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
    Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
    Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome.
    Burke RE; Halpern MS; Baron EJ; Gutierrez K
    Infect Control Hosp Epidemiol; 2009 Jul; 30(7):636-44. PubMed ID: 19496643
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.
    Kourtis AP; Hatfield K; Baggs J; Mu Y; See I; Epson E; Nadle J; Kainer MA; Dumyati G; Petit S; Ray SM; ; Ham D; Capers C; Ewing H; Coffin N; McDonald LC; Jernigan J; Cardo D
    MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(9):214-219. PubMed ID: 30845118
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan.
    Tsuzuki S; Yu J; Matsunaga N; Ohmagari N
    Public Health; 2021 Sep; 198():292-296. PubMed ID: 34507134
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prediction of methicillin-resistant Staphylococcus aureus bloodstream infection: do we need rapid diagnostic tests?
    Delerue T; Cordel H; Delerue T; Figoni J; Dziri S; Billard-Pomares T; Bouchaud O; Carbonnelle E; Zahar JR
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1319-1326. PubMed ID: 30982159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.